News
View the latest company news, press releases, and FDA clearances to see exciting milestones at Acuitive Technologies.
Press Releases
Acuitive Technologies Enters Sport Medicine Market - CITRESPLINE™ & CITRELOCK™
ALLENDALE, NJ., March 4th, 2021
Acuitive Technologies Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRESPLINE™ and CITRELOCK™ Ligament Reconstruction Devices using their patented CITREGEN™ biomaterial technology, a market disruptive bioresorbable synthetic polymer.
Acuitive Technologies Granted FDA 510(k) Clearance for CITREFIX™ Knotless Suture Anchor
ALLENDALE, NJ., February 11th, 2021
Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITREFIX™ Knotless Suture Anchor System with CITREGEN™ material technology, a new generation bioresorbable synthetic polymer.
Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN™ CITRELOCK™ Tendon Interference Screw System
ALLENDALE, NJ., October 21st, 2020
Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRELOCK™ Interference Screw System with CITREGEN™ material technology, a new generation thermoset bioresorbable synthetic polymer now FDA cleared.
Company News
Acuitive Technologies Collaborates with Ireland-Based Research Institute, CÚRAM
GALWAY, IRELAND
Through their collaboration with CÚRAM, Acuitive Technologies Inc. has demonstrated the scientific potential of their paradigm-changing bioactive CITREGEN™ platform technology to expedite tissue healing and mitigate the problems associated with currently marketed biodegradable devices for numerous musculoskeletal applications